The proposed Bone Cells and Signaling Core will enable participating investigators to pursue new lines of research in skeletal biology by using state-of-the-art technologies for bone cell isolation and functional assessment, and by advancing their knowledge of how such systems can be applied to problems in the field. The proposed Core will bring together the expertise and acumen of the two Co-Directors Dr. Pajevic Divieti and Dr. Gardella, and powerful new research approaches and assay systems to make for a synergistic resource that will enrich and catalyze the scientific advances of participating investigators. The Core will enable investigators to obtain directly from skeletal tissue, specific types of cells, such as osteoblasts and osteocytes, in purified form, and to propagate these cells for further detailed study. Also enabled will be the means to knock-down specific genes of interest in these cells using shRNA technologies. The Core will further enable analyses of multiple signal transduction and sub-cellular molecular trafficking mechanisms that operate in such cells using sensitive new biochemical assays, high throughput plate reader technologies, and real-time, high-resolution microscopy approaches. As the Core evolves, it will seek to enable and apply new methods, such as CRISPR and TALON technologies to site-specifically alter target genes in cultured cells, scaffolding methods to grow and assay skeletal cells in three dimensions, and multiarray signaling assays to assess novel drug/modulator action, such as biased agonism and signaling selectivity. Each service provided by the Core will be rigorously controlled for quality performance and reliability. The Core will conduct hands-on training sessions by which investigators can be mentored and taught how to perform assays and cell manipulations on their own. It will also establish a seminar series by which new methodologies, approaches, and related scientific progress can be presented and discussed. By providing these services and functions at efficient costs, with high quality, and with rich education, the Core will reduce research barriers for established and junior investigators, and thus help open new lines of investigation and discovery in the skeletal field.

Public Health Relevance

The proposed research Core will enable and facilitate new research directions and open new opportunity for discovery in the field of skeletal biology. The Core will thus advance the careers of multiple participating investigators and lead to knew understanding of how skeletal systems function in human health.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
5P30AR066261-04
Application #
9285608
Study Section
Special Emphasis Panel (ZAR1-XZ)
Project Start
Project End
Budget Start
2017-06-01
Budget End
2018-05-31
Support Year
4
Fiscal Year
2017
Total Cost
$228,015
Indirect Cost
$96,972
Name
Massachusetts General Hospital
Department
Type
Independent Hospitals
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02114
Noguchi, Takashi; Hussein, Amira I; Horowitz, Nina et al. (2018) Hypophosphatemia Regulates Molecular Mechanisms of Circadian Rhythm. Sci Rep 8:13756
Christov, Marta; Clark, Abbe R; Corbin, Braden et al. (2018) Inducible podocyte-specific deletion of CTCF drives progressive kidney disease and bone abnormalities. JCI Insight 3:
Dedic, Christopher; Hung, Tin Shing; Shipley, Alan M et al. (2018) Calcium fluxes at the bone/plasma interface: Acute effects of parathyroid hormone (PTH) and targeted deletion of PTH/PTH-related peptide (PTHrP) receptor in the osteocytes. Bone 116:135-143
Karaca, Anara; Malladi, Vijayram Reddy; Zhu, Yan et al. (2018) Constitutive stimulatory G protein activity in limb mesenchyme impairs bone growth. Bone 110:230-237
Kiapour, Ata M; Cao, Jiaxue; Young, Mariel et al. (2018) The role of Gdf5 regulatory regions in development of hip morphology. PLoS One 13:e0202785
Farrell, Mariah L; Reagan, Michaela R (2018) Soluble and Cell-Cell-Mediated Drivers of Proteasome Inhibitor Resistance in Multiple Myeloma. Front Endocrinol (Lausanne) 9:218
Cox, Kimberly H; Oliveira, Luciana M B; Plummer, Lacey et al. (2018) Modeling mutant/wild-type interactions to ascertain pathogenicity of PROKR2 missense variants in patients with isolated GnRH deficiency. Hum Mol Genet 27:338-350
Vandoorne, Katrien; Rohde, David; Kim, Hye-Yeong et al. (2018) Imaging the Vascular Bone Marrow Niche During Inflammatory Stress. Circ Res 123:415-427
Herisson, Fanny; Frodermann, Vanessa; Courties, Gabriel et al. (2018) Direct vascular channels connect skull bone marrow and the brain surface enabling myeloid cell migration. Nat Neurosci 21:1209-1217
Wein, Marc N; Foretz, Marc; Fisher, David E et al. (2018) Salt-Inducible Kinases: Physiology, Regulation by cAMP, and Therapeutic Potential. Trends Endocrinol Metab 29:723-735

Showing the most recent 10 out of 53 publications